"Clinical Research Hamburg ist ein ambulantes Prüfzentrum im Zentrum vom Hamburg Rahlstedt für klinische Forschung der Phasen II, III und IV aus den verschiedensten Indikationsbereichen der Humanmedizin. Unter den Stichwort "Wir forschen für Ihre Gesundheit" werden bei Clinical Research Patienten in Rahmen von klinischen Studien behandelt."

During the past decade, Clinical Research Hamburg GmbH conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Research Hamburg GmbH" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Janssen Vaccines & Prevention B.V." with 2 trials sponsored, "Allergan" with 1 trials sponsored, "Fresenius Kabi SwissBioSim GmbH" with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research Hamburg GmbH" #1 collaborator was "Labor Dr. Spranger (Central lab)" with 1 trials as a collaborator, "Laboratorios LETI SL (Study Medication)" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Pierrel Research Europe GmbH" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Research Hamburg GmbH" are "Psoriasis" (3 trials), "Acute Respiratory Infection" (1 trials), "Allergic Rhinitis and/or Rhinoconjunctivitis +- Asthma" (1 trials), "COVID-19 Prevention" (1 trials) and "Gastroparesis" (1 trials). Many other conditions were trialed in "Clinical Research Hamburg GmbH" in a lesser frequency.

Most popular intervention types in "Clinical Research Hamburg GmbH" are "Drug" (5 trials), "Biological" (4 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Mirikizumab" (2 trials), "Placebo" (2 trials), "Ad26.COV2.S" (1 trials), "Ad26.RSV.preF-based Vaccine" (1 trials) and "Allergoid, allergenic extract of 100% Birch" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Research Hamburg GmbH" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Clinical Research Hamburg GmbH". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Clinical Research Hamburg GmbH, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research Hamburg GmbH, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".